I
Integrum AB
STO:INTEG B
Integrum AB
STO:INTEG B
Price:
9.47
SEK
-2.97%
Market Closed
Market Cap:
kr246.5m
Relative Value
The Relative Value of one INTEG B stock under the Base Case scenario is 20.65 SEK. Compared to the current market price of 9.47 SEK, Integrum AB is Undervalued by 54%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
INTEG B
Relative Value
Base Case
20.65
SEK
Undervaluation 54%
I
Multiples Across Competitors
INTEG B Competitors Multiples
Integrum AB Competitors
Integrum AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
I
|
Integrum AB
STO:INTEG B
|
246.5m SEK | 2.5 | -8.3 | -5.3 | -5.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
188.9B USD | 4.3 | 28.9 | 16.4 | 22.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172B USD | 17.1 | 60.1 | 45.8 | 55.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138.8B USD | 5.5 | 42.8 | 21.7 | 26.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.1B USD | 3.8 | 27.5 | 15.4 | 22.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
114.7B USD | 5.9 | 40.9 | 24.3 | 33.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD | 2.7 | 35.6 | 13 | 22.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR | 2.1 | 22.6 | 12.7 | 18 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.7B USD | 12.3 | 49.9 | 35.9 | 39.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46.7B USD | 7.9 | 34.1 | 24.2 | 26.6 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
37.8B USD | 1.9 | 17.1 | 12.7 | 15.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
